Skip to main content

Table 1 Patient characteristics

From: Coronary flow velocity reserve by echocardiography: feasibility, reproducibility and agreement with PET in overweight and obese patients with stable and revascularized coronary artery disease

  Feasibility (n = 86) Reproducibility (n = 21) Method agreement (n = 35)
Male gender 72 (84 %) 20 (95 %) 32 (91 %)
Age [years] 63 (57–67) 63 (58–67) 63 (60–69)
Height [m] 1.74 (1.69–1.78) 1.75 (1.72–1.82) 1.77 (1.70–1.77)
Weight [kg] 92.8 (85.6–100.5) 90.6 (82.1–97.4) 92.8 (85.4–101.0)
BMI [kg × m−2] 30.9 (29.4–32.9) 29.0 (26.3–32.1) 30.8 (28.9–32.1)
MI 51 (59 %) 12 (57 %) 18 (51 %)
MILAD 26 (30 %) 8 (38 %) 12 (34 %)
CABG 18 (21 %) 8 (38 %) 9 (26 %)
Atrial fibrillation 7 (8 %) 2 (10 %) 2 (6 %)
Use of contrast 12 (14 %) 1 (5 %) 8 (23 %)
CFVR 2.29 (1.90–2.63) 2.27 (1.82–2.69) 2.39 (1.89–3.04)
  1. Categorical and continuous variables expressed as count (%) and median (IQR), respectively. BMI body mass index, MI myocardial infarction, LAD left anterior descending artery territory, CABG coronary artery bypass graft, CFVR coronary flow reserve by transthoracic Doppler echocardiography. No significant differences between participants and non- participants in reproducibility and PET study. P = 0.061(Fisher’s exact) for CABG in reproducibility study. P = 0.057 (Fisher”s exact) for contrast usage in PET study